13 results · 19ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

VAX-D GENESIS SYSTEM (THERAPEUTIC TABLE)

FDA 510(k)
FDA Class 2 ·Physical Medicine

JOBST forMen

FDA UDI
BSN MEDICAL, INC.·04042809843828·FOR MEN 30-40 MM HG KNEE HIGH CLOSED TOE EXTRA ...

Arx

FDA UDI
Life Spine, Inc.·00190837124472·

Arx

FDA UDI
Life Spine, Inc.·00190837130633·

MODIFICATION TO: STERILE COLLES CLASSIC FIXATOR

FDA 510(k)
FDA Class 2 ·Orthopedic

N LATEX CYSTATIN C

FDA 510(k)
FDA Class 2 ·Clinical Chemistry

HOMECHOICE AUTOMATED PD SET WITH CASSETTE

FDA Adverse Event
Malfunction ·BAXTER HEALTHCARE - MOUNTAIN HOME·Product code FKX·April 11, 2013

1ST RESPONSE RESUSCITATOR, INFANT

FDA Adverse Event
Malfunction ·SMITHS MEDICAL ASD, INC. BY: GALEMED CORPORATION·Product code BTM·May 28, 2008

CAPSUREFIX NOVUS

FDA Adverse Event
Injury ·MEDTRONIC PUERTO RICO, INC.·Product code DTB·April 13, 2011

CABLE TENSIONER

FDA Adverse Event
Malfunction ·SYNTHES MONUMENT·Product code LXH·April 8, 2016

Conformer - Medium (Sterile)

FDA Recall
Terminated ·Gulden Ophthalmics·Product code HQX·November 29, 2002

Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

Boston Scientific COGNIS CRT-D, Cardiac Resynchronization Therapy Defibrillator, models N118, N119. The following models are not available in the US: models N106, N107, P106, P107. Sterilized using ethylene oxide. Product Usage: Boston Scientific cardiac resynchronization therapy defibrillators (CRT-Ds) are indicated for patients with moderate to severe heart failure who remain symptomatic despite stable, optimal heart failure drug therapy and have left ventricular dysfunction and QRS duration > or equal to 120 ms. This family of pulse generators provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Cardiac Resynchronization Therapy (CRT), which treats heart failure by resynchronizing ventricular contractions through biventricular electrical stimulation; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy.

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014